Source-grounded facts extracted from PROKIDNEY CORP.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
PROKIDNEY CORP.: Adoption of new Bylaws in connection with domestication from Cayman Islands to Delaware.
“ProKidney Delaware adopted a certificate of incorporation (the “Certificate of Incorporation”) and bylaws (the “Bylaws”), and the rights of holders of the Common Stock are now governed by such documents and the DGCL.”
PROKIDNEY CORP.: Adoption of new Certificate of Incorporation in connection with domestication from Cayman Islands to Delaware.
“ProKidney Delaware adopted a certificate of incorporation (the “Certificate of Incorporation”) and bylaws (the “Bylaws”), and the rights of holders of the Common Stock are now governed by such documents and the DGCL.”
PROKIDNEY CORP.: Adopted new Bylaws in connection with Domestication from Cayman Islands to Delaware.
“The Certificate of Incorporation and Bylaws were effective as of the Domestication Date.”
PROKIDNEY CORP.: Adopted new Certificate of Incorporation in connection with Domestication from Cayman Islands to Delaware.
“The Certificate of Incorporation and Bylaws were effective as of the Domestication Date.”
PROKIDNEY CORP. reported financial results for the first quarter ended March 31, 2024.
“On May 10, 2024, ProKidney Corp. issued a press release to announce its financial results for the quarter ended March 31, 2024.”
Ulrich Ernst was appointed as Executive Vice President, Technical Operations at PROKIDNEY CORP..
“On March 25, 2024, ProKidney Corp. (the “Company”) announced the appointment of Ulrich Ernst, Ph.D. as the Company’s Executive Vice President, Technical Operations effective as of March 25, 2024.”
PROKIDNEY CORP. reported financial results for the year ended December 31, 2023.
“ProKidney Corp. issued a press release to announce its financial results for the year ended December 31, 2023.”
Deepak Jain resigned as Chief Operating Officer at PROKIDNEY CORP..
“On March 13, 2024 (the “Effective Date”), the Company entered into a Separation Agreement (the “Separation Agreement”) with Dr. Jain.”
Dr. Bertram departed as ceo at PROKIDNEY CORP..
“On March 13, 2024 (the “Effective Date”), the Company entered into a Separation Agreement (the “Separation Agreement”) with Dr. Bertram.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.